Pharmacogenetic association of NOS3 variants with cardiovascular disease in patients with hypertension: the GenHAT study.

Nitric oxide synthase 3 (NOS3) catalyzes production of NO in the endothelium and may play a role in cardiovascular disease (CVD). We assessed the pharmacogenetic associations of three NOS3 polymorphisms and three antihypertensive drugs with CVD outcomes. Hypertensive subjects (n = 30,280) from a mul...

Full description

Saved in:
Bibliographic Details
Main Authors: Xue Zhang, Amy I Lynch, Barry R Davis, Charles E Ford, Eric Boerwinkle, John H Eckfeldt, Catherine Leiendecker-Foster, Donna K Arnett
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0034217&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!